Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by MAKSIM MAMONKIN and LAQUISA HILL.
MAKSIM MAMONKIN
Connection Strength
1.492
LAQUISA HILL
  1. Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas. Blood. 2024 03 28; 143(13):1231-1241.
    View in: PubMed
    Score: 0.895
  2. Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity. Cell Rep Med. 2024 Jul 16; 5(7):101628.
    View in: PubMed
    Score: 0.228
  3. Feasibility and preclinical efficacy of CD7-unedited CD7 CAR T?cells for T?cell malignancies. Mol Ther. 2023 01 04; 31(1):24-34.
    View in: PubMed
    Score: 0.201
  4. International Consensus Guidelines for the Conduct and Reporting of CAR T-Cell Clinical Trials in AML. Blood Adv. 2025 Aug 19.
    View in: PubMed
    Score: 0.062
  5. Targeting IDH2R140Q and other neoantigens in acute myeloid leukemia. Blood. 2024 04 25; 143(17):1726-1737.
    View in: PubMed
    Score: 0.056
  6. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.